Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

United States

Highlands Oncology Group, PA, Fayetteville, Arkansas

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Highlands Oncology Group, PA, Rogers, Arkansas

Highlands Oncology Group, PA, Springdale, Arkansas

Perlmutter Cancer Center at NYU Langone Health, Mineola, New York

Perlmutter Cancer Center at NYU Langone Health, New York, New York